Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001013762-14-001054
Filing Date
2014-08-28
Accepted
2014-08-28 17:03:40
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 DELMAR PHARMACEUTICALS FORM 10-KT form10kt.htm 10-KT 1919504
2 EXHIBIT 31.1 ex311.htm EX-31.1 14848
3 EXHIBIT 31.2 ex312.htm EX-31.2 14810
4 EXHIBIT 32.1 ex321.htm EX-32.1 6738
5 EXHIBIT 32.2 ex322.htm EX-32.2 6574
6 GRAPHIC table.jpg GRAPHIC 33020
7 GRAPHIC table2.jpg GRAPHIC 29028
  Complete submission text file 0001013762-14-001054.txt   10009832

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dmpi-20140630.xml EX-101.INS 1418262
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dmpi-20140630.xsd EX-101.SCH 94681
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmpi-20140630_cal.xml EX-101.CAL 37636
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmpi-20140630_def.xml EX-101.DEF 302740
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE dmpi-20140630_lab.xml EX-101.LAB 608340
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmpi-20140630_pre.xml EX-101.PRE 462193
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-KT | Act: 34 | File No.: 000-54801 | Film No.: 141072537
SIC: 2834 Pharmaceutical Preparations